Literature DB >> 24365641

Biosimilars in Crohn's disease.

Morton Scheinberg1.   

Abstract

Entities:  

Mesh：

Substances：

Year:  2013        PMID： 24365641     DOI： 10.1016/j.crohns.2013.12.002

Source DB:  PubMed          Journal:  J Crohns Colitis        ISSN： 1873-9946            Impact factor:   9.071


× No keyword cloud information.
  2 in total

1.  Therapy: Facing up to biosimilar agents--the ACR position.

Authors:  Morton Scheinberg
Journal:  Nat Rev Rheumatol       Date:  2015-04-28       Impact factor: 20.543

Review 2.  Anti-tumor necrosis factor patent expiration and the risks of biocopies in clinical practice.

Authors:  Morton Scheinberg; Gilberto Castañeda-Hernández
Journal:  Arthritis Res Ther       Date:  2014-12-06       Impact factor: 5.156
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.